Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

Jay D. Hatfield, CEO of Infrastructure Capital Advisors, says he's "bullish on financials, but more bullish on investment banks," as he expects not only an M&A boom "because of more reasonable ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Macy's CEO Tony Spring, who is trying to turn around the company, wants to prove to the public markets that its three-brand ...